BSE Live
Dec 30, 09:04Prev. Close
1136.30
Open Price
0.00
Bid Price (Qty.)
1301.00 (18)
Offer Price (Qty.)
1136.30 (100)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Profit & Loss account of Kwality Pharmaceuticals (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 52.38 | 59.60 | 61.74 | 37.95 | 37.02 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 52.38 | 59.60 | 61.74 | 37.95 | 37.02 | |
| Total Operating Revenues | 52.38 | 59.60 | 61.74 | 37.95 | 37.02 | |
| Other Income | 0.58 | 0.17 | 0.19 | 1.43 | 1.00 | |
| Total Revenue | 52.96 | 59.76 | 61.94 | 39.38 | 38.01 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 37.50 | 46.17 | 47.49 | 29.41 | 28.37 | |
| Purchase Of Stock-In Trade | 0.10 | 0.00 | 2.19 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 0.88 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Employee Benefit Expenses | 2.02 | 1.79 | 1.39 | 1.10 | 1.31 | |
| Finance Costs | 1.03 | 0.74 | 0.99 | 1.38 | 1.18 | |
| Depreciation And Amortisation Expenses | 1.30 | 1.20 | 0.92 | 1.06 | 1.12 | |
| Other Expenses | 8.26 | 8.06 | 7.33 | 5.41 | 5.21 | |
| Total Expenses | 51.09 | 57.96 | 60.32 | 38.36 | 37.19 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1.87 | 1.80 | 1.62 | 1.02 | 0.82 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 1.87 | 1.80 | 1.62 | 1.02 | 0.82 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.59 | 0.51 | 0.43 | 0.30 | 0.43 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -0.04 | 0.34 | 0.01 | 0.10 | 0.10 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 0.55 | 0.85 | 0.44 | 0.40 | 0.53 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 1.32 | 0.95 | 1.18 | 0.62 | 0.30 | |
| Profit/Loss From Continuing Operations | 1.32 | 0.95 | 1.18 | 0.62 | 0.30 | |
| Profit/Loss For The Period | 1.32 | 0.95 | 1.18 | 0.62 | 0.30 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 3.00 | 2.60 | 3.32 | 1.76 | 0.85 | |
| Diluted EPS (Rs.) | 3.00 | 2.60 | 3.32 | 1.76 | 0.85 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
04.12.2025
Kwality Pharmac Consolidated September 2025 Net Sales at Rs 111.05 crore, up 23.34% Y-o-Y
27.11.2025
Kwality Pharmac Standalone September 2025 Net Sales at Rs 111.31 crore, up 23.63% Y-o-Y
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y
04.12.2025
Kwality Pharmac Consolidated September 2025 Net Sales at Rs 111.05 crore, up 23.34% Y-o-Y
27.11.2025
Kwality Pharmac Standalone September 2025 Net Sales at Rs 111.31 crore, up 23.63% Y-o-Y
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y